Merck (MRK) Tax Provisions (2009 - 2026)

Merck (MRK) has reported Tax Provisions for 18 consecutive years, with $654.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Tax Provisions rose 14.54% year-over-year to $654.0 million in Q2 2026; TTM through Jun 2026 was $2.8 billion, a 1.28% increase from a year earlier, with the FY2025 full-year figure at $2.8 billion, changed 0.04% from the prior year.
• Tax Provisions was $654.0 million for Q2 2026 at Merck, down from $709.0 million in the prior quarter.
• Over five years, Tax Provisions peaked at $958.0 million in Q3 2025 and troughed at -$820.0 million in Q4 2023.
• A 5-year average of $577.8 million and a median of $604.0 million in 2023 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions jumped 482.35% in 2022 and tumbled 265.66% in 2023, its largest moves.
• Over 5 years, Tax Provisions stood at $495.0 million in 2022, then plunged by 265.66% to -$820.0 million in 2023, then jumped by 151.95% to $426.0 million in 2024, then advanced by 7.51% to $458.0 million in 2025, then surged by 42.79% to $654.0 million in 2026.
• The last three Tax Provisions figures came in at $654.0 million (Q2 2026), $709.0 million (Q1 2026), and $458.0 million (Q4 2025), per Business Quant data.